Filter
2575
Filtered Results: 2575
Text search:
vih
Featured
Recommendations
216
New Publications
867
Language
Document type
No document type
1531
Guidelines
387
Studies & Reports
297
Strategic & Response Plan
107
Manuals
93
Fact sheets
53
Training Material
49
Situation Updates
21
Infographics
15
Brochures
12
Resource Platforms
9
Online Courses
1
Countries / Regions
India
117
Congo, Democratic Republic of
115
Senegal
111
Latin America and the Carribbean
79
Burkina Faso
77
Paraguay
72
Kenya
69
Tanzania
63
Venezuela
61
Argentina
61
Benin
60
Haiti
60
Colombia
58
Global
50
Peru
40
Cambodia
39
Nigeria
38
Nepal
35
Cameroon
33
Malawi
32
Central African Republic
32
Zambia
31
Madagascar
31
Ethiopia
30
Indonesia
30
Uganda
29
Rwanda
25
El Salvador
24
Bolivia
23
Bangladesh
22
Myanmar / Burma
22
Ghana
20
South Africa
19
Lesotho
18
Mozambique
18
Brazil
18
Ecuador
18
Guinea
17
Africa
15
West and Central Africa
14
Chile
12
Philippines
12
Namibia
12
Niger
11
Mali
11
Sierra Leone
10
Togo
9
Zimbabwe
9
East and Southern Africa
9
Côte d’Ivoire / Ivory Coast
9
Liberia
9
Western and Central Europe
8
Angola
8
Botswana
8
Guinea-Bissau
6
Ukraine
5
Uruguay
5
Spain
5
Chad
5
Burundi
4
Germany
4
Middle East and North Africa
4
South–East Asia Region
4
Eswatini/ Swaziland
4
Pakistan
4
Guatemala
4
Mexico
3
France
3
Vietnam
3
Eastern Europe
3
Russia
3
Honduras
3
Switzerland
2
Timor Leste/ East Timor
2
Congo-Brazzaville
2
Asia
2
Dominican Republic
2
Eastern Europe and Central Asia
2
Nicaragua
2
North Macedonia
1
Armenia
1
Western Pacific Region
1
Gabon
1
Jamaica
1
Belgium
1
Belarus
1
Southern Africa
1
Egypt
1
Georgia
1
South Sudan
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
1609
Clinical Guidelines
216
Women & Child Health
108
Key Resources
65
Public Health
50
Capacity Building
25
Pharmacy & Technologies
18
Toolboxes
TB
352
HIV
208
COVID-19
173
Mental Health
89
NTDs
60
Disability
51
Rapid Response
39
Caregiver
39
Ebola & Marburg
34
AMR
34
Refugee
25
Pharmacy
25
Zika
17
Conflict
14
Polio
13
Planetary Health
12
Cholera
11
Natural Hazards
10
Health Financing Toolbox
8
NCDs
6
Malaria
4
Global Health Education
2
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
This document describes the key areas that national governments should consider for the introduction and scale-up of point-of-care (POC) diagnostics within national programmes, as new innovative POC technologies are being introduced into the market. The next steps taken to include these new innovati...
Men experience increased risk of morbidity and mortality across all ten major contributors to poor health and continue to lag behind women regarding HIV services and other health outcomes. Globally, men now account for the majority of new HIV infections. In 2022, only 72% of men living with HIV (age...
2nd edition
Supplement
HIV testing services
December 2016
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
